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.Introduction: Inferior vena caval ﬁlters are often seen as a safe and effective means of preventing pulmonary
embolism in at-risk patients who have contraindications to pharmacological therapy. Filter migration is a rare
event and there is no description in the literature with the Braile dual ﬁxing system ﬁlter.
Report: This is a report of a case where ﬁlter embolization to the right atrium in a 60-year-old male patient led to
tricuspid insufﬁciency, sepsis, and death.
Discussion: We would like to emphasize the “sailing effect” that probably occurred in this case.
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Inferior vena cava ﬁlters (IVCFs) are used as a safe and
effective means for the prevention of pulmonary embolism
(PE) in high-risk patients who have contraindications to
pharmacologic therapy.
We report here a patient who developed deep venous
thrombosis (DVT) after brain abscess surgery, and was then
implanted with an ICVF. The ﬁlter migrated to the atrium
causing tricuspid insufﬁciency and death. This is the ﬁrst
report of a permanent IVCF with a dual ﬁxing system
embolizing to the heart.REPORT
A 60-year-old man with right-sided hemiparesis on the ﬁfth
day following brain abscess surgery presented right iliofemoral
venous thrombosis detected by color-Doppler ultrasound.
Anticoagulant medication was contraindicated because of the
recent neurosurgery. On the 15th post-operative day, a per-
manent 18e22 mm IVCF was implanted uneventfully via the
left femoral vein. Before releasing the ﬁlter a cavography was
performed for caval diameter measurement (Fig. 1). On the
seventh post-implant day there was a progressive deteriora-
tion of cardiac function. A transesophageal echocardiography
performedon the eighth day showed amassmeasuring 3.1 cm
at the largest diameter located in the right atrium. At the same
examination, tricuspid valve vegetation on the atrial side,
reﬂux, pulmonary hypertension, and substantial pericardial
effusion were also found. The effusion culture was negative.
The clinical instability of the patient was accredited to endo-
carditis. A thoraco-abdominal tomography was performed to
investigate a possible IVCF infection and showed a metallic
object in the right atrium (Fig. 2). A cardiotomywasperformed,of original article: http://dx.doi.org/10.1016/j.ejvs.2013.09.001
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and a tricuspid valvuloplasty was performed. Two days after
the procedure the patient died as a result of septic shock.DISCUSSION
IVCFs are used for the prevention of PEs in at-risk patients
with contraindications to anticoagulation, and patients with
venous thromboembolism (VTE) who have failed anti-
coagulation.1 In the case presented here, anticoagulation
therapy was not permitted because of recent neurosurgery.
The Braile permanentﬁlter, available in 18e28mmand28e
32 mm diameters has been available on the Brazilian market
for more than 7 years.2 It comprises two stainless steel cones
set at opposite apices with an hourglass shape. One cone
measures 5 cm in length and has eight legs with hooks for
anchoring to the venous wall. The other cone consists of four
arms, 2 cm in length, and acts to afﬁx and center the system.
This dual ﬁxing system is designed to prevent migration.
Therefore, it was surprising to discover that the ﬁlter had
dislodged from the IVC and embolized to the atrium.
Filtermigration is a rare complication, and is deﬁned asﬁlter
movement of at least 1 cm in a cranial or caudal position.3
The causes of migration can be grouped into three cat-
egories: mechanical, iatrogenic, and physiological. Me-
chanical causes are related to failure of the delivery device
or of the ﬁlter itself. These generally occur during the
deployment process. Iatrogenic causes include guide-wire
and central venous access complications. Releasing the ﬁl-
ter without knowing the diameter of the IVC is another
cause of migration. Literature shows that caval diameters
greater than 28 mm increase the probability of migration.
Despite this observation, measurements of the IVC diam-
eter were reported in only 18.4% of the cases in which
complications occurred. IVC diameter, renal vein localiza-
tion, and exclusion of vascular anomalies should be estab-
lished in all patients for safe deployment.4
A physiological cause of IVC ﬁlter migration could be a
temporary alteration in the morphology of the IVC. Bending
over, coughing, and Valsalva maneuvers can dilate the cava
Figure 1. Phlebography, pre (A) and post (B) implant. Observe the correct position of the double anchorage system ﬁlter (arrows).
Figure 2. Tomography showing evidence of a metallic object in the right atrium (arrows). (A) Coronal and (B) sagittal axes.
e50 A.N. Farret et al.and permit ﬁlter migration. A “sailing effect” by blood ﬂow
has been proposed by Rossi et al.,5 which may induce
migration of conical ﬁlters to the heart. This may be a
potentially important factor when the ﬁlter stores a large
thrombus burden. We assume that this effect played a role
in our case, as there was no anatomical variation, no
technical difﬁculty implanting the ﬁlter, and its diameter
was appropriate for the IVC.
We emphasize that ICVFs are not free of complications.
These can be serious; therefore, indications for ﬁlter
placement should be followed. Finally, we suggest that after
implantation, patients should follow up with imaging
studies to assess the ﬁlter’s position.
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